Data / Form D filings / Cantai Therapeutics, Inc.
Cantai Therapeutics, Inc.: Form D filings
Cantai Therapeutics, Inc., a biotechnology company in Philadelpia, PA, filed 4 Form D notices with the SEC between 2023 and 2026. The latest, on January 21, 2026, reports $3 million sold of a $3 million offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3675 MARKET STREET SUITE 200, Philadelpia, PA, 19104
- Phone
- (603) 996-1218
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1991732
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | New notice | $3,000,000 | $3,000,000 | 3 | Jan 15, 2026 | sec.gov | |
| Jul 15, 2025 | New notice | $1,100,000 | $550,000 | $550,000 | 3 | Jul 2, 2025 | sec.gov |
| Nov 20, 2023 | Amendment | $3,000,000 | $700,000 | $2,300,000 | 3 | Nov 6, 2023 | sec.gov |
| Nov 20, 2023 | New notice | $30,000,000 | $700,000 | $29,300,000 | 3 | Nov 6, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ross Leimberg | Executive Officer, Director | |
| Errik B. Anderson | Executive Officer | |
| Getta Vemuri | Executive Officer, Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Jan 19, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cantai Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.